ATON
AlphaTON Capital Corp. NASDAQ Listed Jan 2, 2002$0.27
Mkt Cap $612,637
52w Low $0.18
0.7% of range
52w High $13.80
50d MA $0.36
200d MA $3.14
P/E (TTM)
-0.0x
EV/EBITDA
-1.4x
P/B
—
Debt/Equity
0.0x
ROE
-108.2%
P/FCF
-2.0x
RSI (14)
—
ATR (14)
—
Beta
0.49
50d MA
$0.36
200d MA
$3.14
Avg Volume
5.2M
About
AlphaTON Capital Corp. is the rebranded entity formerly known as Portage Biotech Inc., a clinical-stage immuno-oncology company transitioning into a digital asset treasury model focused on accumulating and staking Toncoin (TON). AlphaTON intends to invest significantly in TON tokens, targeting a Long-Term TON treasury of approximately US $100 million.
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | AMC | -0.35 | -4.13 | -1080.0% | 0.91 | +100.0% | +42.9% | +0.8% | -6.6% | -17.5% | +1.4% | — |
| Jan 5, 2026 | AMC | -4.20 | -1.26 | +70.0% | 0.80 | +4.8% | +24.8% | +29.8% | +13.6% | +12.4% | +13.6% | — |
| Oct 8, 2025 | AMC | — | -2.57 | — | 10.91 | -27.4% | -23.5% | -42.3% | -40.1% | -34.6% | -40.2% | — |
| Mar 28, 2025 | AMC | — | -0.17 | — | 9.60 | -10.4% | -3.6% | -14.0% | -27.3% | -37.2% | -42.4% | — |
| Nov 26, 2024 | AMC | — | -1.26 | — | 4.87 | -1.4% | -13.6% | -14.2% | -17.0% | -18.3% | -15.6% | — |
| Aug 27, 2024 | AMC | — | -1.58 | — | 6.39 | +0.0% | +4.1% | -29.3% | -46.0% | -42.1% | -40.4% | — |
| Jun 6, 2024 | AMC | -0.22 | -1.26 | -471.8% | 5.80 | -2.1% | -8.3% | -2.4% | -5.7% | -11.4% | -12.4% | — |
| Feb 28, 2024 | AMC | -5.40 | -3.60 | +33.3% | 14.00 | +0.0% | -15.7% | -19.4% | -20.0% | -19.4% | -18.6% | — |
| Nov 28, 2023 | AMC | -5.40 | -5.80 | -7.4% | 28.20 | -4.8% | +0.0% | -5.7% | -4.3% | -13.5% | -12.1% | — |
| Aug 30, 2023 | AMC | -4.80 | -6.60 | -37.5% | 53.20 | +0.0% | -3.8% | -11.7% | +12.0% | +1.1% | +4.5% | — |
Data updated apr 27, 2026 11:02pm
· Source: massive.com